Augmentation in the treatment of restless legs syndrome with transdermal rotigotine
Sleep Medicine, 06/29/2012
Clinical Article
Benes H et al. – The analyses suggest that the risk for clinically relevant augmentation for the duration of up to 18months of rotigotine treatment is low.



